Tumor necrosis factor inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tumor necrosis factor inhibitor (unspecified), covering 2024-10-30 to 2024-10-30. Get the full timeline:
Most recent: Clinical Trial Update: Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease [Phase 2]